ID: ALA605663

Max Phase: Preclinical

Molecular Formula: C15H24N2O16P2

Molecular Weight: 550.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1ccn(C2O[C@H](COP(=O)(O)CP(=O)(O)OC3OC(O)C(O)C(O)C3O)[C@@H](O)[C@H]2O)c(=O)[nH]1

Standard InChI:  InChI=1S/C15H24N2O16P2/c18-6-1-2-17(15(25)16-6)12-9(21)7(19)5(31-12)3-30-34(26,27)4-35(28,29)33-14-11(23)8(20)10(22)13(24)32-14/h1-2,5,7-14,19-24H,3-4H2,(H,26,27)(H,28,29)(H,16,18,25)/t5-,7-,8?,9-,10?,11?,12?,13?,14?/m1/s1

Standard InChI Key:  YXDPDZXUCYFTSS-PAMMDAJRSA-N

Associated Targets(non-human)

Beta-1,4-galactosyltransferase 1 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 550.30Molecular Weight (Monoisotopic): 550.0601AlogP: -4.73#Rotatable Bonds: 8
Polar Surface Area: 287.76Molecular Species: ACIDHBA: 15HBD: 9
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.76CX Basic pKa: CX LogP: -5.26CX LogD: -9.88
Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.14Np Likeness Score: 1.33

References

1. Schmidt RR, Frische K.  (1993)  A new galactosyl transferase inhibitor,  (8): [10.1016/S0960-894X(00)80055-4]

Source